ARCHIVES

Velcade Plus Dexamethasone Provides 20% Response In First-Line Treatment

This article is from The Cancer Letter archive.

Vol. 29 No. 12 | December 29, 2006

Download PDF Visit The Full Archive

Related Articles

Taxotere Added To Regimen Improves Survival, Study Finds

July 29, 2005

Rosenberg Begins Trial To Immunize Patient against Tumor

October 11, 1991

Long-Term Estrogen Use May Increase Ovarian Cancer Risk

April 27, 2001

Consensus Conference On Receptors Planned

June 22, 1979

Combine Phase 1-2, Abolish DRG, Slash Indirect Costs, Garb Tells Congress

November 27, 1981

House Bill Gives NCI $135 Million Increase, NIH $846 Million for FY 1988 Over 1987 Budgets

August 7, 1987